Keywords
Cognitive Dysfunction - Stroke - Cerebral Circulation
Palavras-chave
Disfunção Cognitiva - Acidente Vascular Cerebral - Circulação Cerebral
INTRODUCTION
It has been demonstrated that cerebral infarction frequently results in cognitive
dysfunction, also known as poststroke cognitive impairment (PSCI), which ranges from
mild cognitive impairment (MCI) to dementia. Up to 4 years after a stroke, ∼ 23 to
30% of the patients with cerebral infarction develop MCI or dementia.[1]
[2] The 2016 American Heart Association/American Stroke Association (AHA/ASA) guidelines
recommended that the cognitive status of stroke patients be assessed during hospitalization
in the acute phase.[3] The first step toward reducing vascular risk factors and improving outcomes is to
detect CI early in the acute phase of stroke.[4]
[5] As a result, CI during the acute phase should not be overlooked, and its potential
risk factors and mechanism must be clinically evaluated.
Computed tomography perfusion (CTP) is a functional examination of brain tissue that
characterizes the state of cerebral perfusion and has the highest accuracy in the
diagnosis of anterior circulation ischemic stroke.[6] Furthermore, various studies[7] have recently revealed that CTP might become an important alternative for the visualization
of cerebral and neuronal functional deficits in early dementia. There is a positive
correlation between cognitive function and brain perfusion, and a study[8] has reported that significant brain perfusion corresponded to significant improvement
in cognitive function. However, the relationship between CTP and CI during the acute
phase of stroke remains unknown. Therefore, in the current study, we have analyzed
the association between CTP in different lobes and CI during the acute phase of stroke
in patients with cerebral infarction.
METHODS
Subjects
We included 249 patients with new-onset cerebral infarction admitted to the Neurology
Department of the Third Affiliated Hospital of Anhui Medical University between August
2019 and July 2021. After excluding several subjects who did not meet the inclusion
criteria, 96 patients were included in the study ([Figure 1]). The inclusion criteria were as follows: 1) patients who met the diagnostic criteria
for cerebral infarction of the 2015 Cerebrovascular Disease Classification and were
confirmed to have ischemic stroke by brain CT or diffusion-weighted imaging (DWI);
2) subjects whose first onset time was ≤ 72 hours; 3) patients aged between 45 and
79 years; 4) subjects with an etiology of acute cerebral infarction of the atherosclerotic
type; 5) patients who were clearly conscious without severe aphasia (according to
item 9 of the National Institutes of Health Stroke Scale [NIHSS]; the score of language
plate is of ≤ 1 point); and 6) subjects with no recent history of surgery and trauma,
with stable vital signs. The exclusion criteria were as follows: 1) subjects with
CI, dementia, or other diseases that can affect cognitive and emotional functions
before the onset of the disease; 2) patients with previous large-area cerebral infarction,
cerebral hemorrhage, or traumatic brain injury; 3) subjects with a history of severe
liver, kidney, and heart disease; 4) patients with a recent history of surgery and
trauma, and those with unstable vital signs; 5) subjects who had taken drugs that
affect cognitive function, mood and emotion in the previous month; 6) patients allergic
to iodine who cannot undergo a contrast examination; and 7) subjects with severe visual
or hearing impairment, dysarthria, aphasia, etc. who cannot cooperate with the examination.
All subjects in the control group were aged between 45 and 79 years, without new infarctions
on DWI, with a history of stroke, CI, dementia and mental illness, heart, lung, liver,
and kidney dysfunction, and vision and hearing impairment, self-care, social adaptation
is good, allergic to iodine, and their level of schooling was matched with that of
the case group. The Ethics Committee of the Third Affiliated Hospital of Anhui Medical
University (Heifei First Peoples Hospital) approved the study (under no. 2016[51])].
All participants provided written informed consent. All study procedures were conducted
following the Declaration of Helsinki.
Figure 1 Flowchart of the recruitment and exclusion of patients.
Assessment of cognitive function
The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool that
has been used to assess cognitive function during hospitalization in the acute phase
of an ischemic stroke (the first four weeks after onset).[5]
[9]
[10]
[11] Scores are assigned to seven domains of cognition: language, naming, attention,
abstraction, delayed recall, visuospatial function, and orientation.[10] Cognitive function was classified as follows based on the recommended cutoff scores:
0 to 19–severe CI; 20 to 24–MCI; and 25 to 30–no CI.[12]
CTP imaging
A dual-source CT scanner was used to perform CTP after a conventional plain head CT
scan (Somatom Definition Flash, Siemens Healthcare GmbH, Erlangen, Germany). The scanning
parameters were as follows: tube voltage of 80 kV, tube current of 180 mA, slice thickness
of 1.5 mm, pitch of 1.0 mm, collimation of 64 × 0.6 mm, and matrix of 512 × 512. The
scanning was repeated 30 times at 1.5-second scan time and 4-second intervals. A double-tube
high-pressure syringe was used to inject iohexol 350 mg/mL (50 mL) + saline (40 mL)
intravenously into the right median cubital vein at 6 mL/s.
A computer was used to automatically eliminate vascular pixels to reduce the salience
of the vascular structure. The CTP includes four parameters: cerebral blood flow (CBF),
cerebral blood volume (CBV), time to peak (TTP), and mean transit time (MTT).
Statistical analysis
The Statistical Package for the Social Sciences (SPSS for Widows, SPSS Inc., Chicago,
IL, United States) software, version 16.0, was used for data analysis. The categorical
data were expressed as numbers and percentages, and the continuous data, as mean and
standard deviation (SD) values. The differences between the two groups were compared
using the t-test; the rank-sum test was used to compare data with skewed distribution; the Chi-squared
test was used to compare count data between the two groups; analysis of variance (ANOVA)
was used to assess differences in measurement data among multiple groups; and the
Duncan multi-range test was used. Statistical significance analysis was performed.
A multivariate analysis was conducted using linear regression. Statistical significance
was set at p < 0.05.
RESULTS
Baseline characteristics
At the baseline of observation analyses, 96 patients with new-onset anterior circulation
cerebral infarction were included. Their mean age was of 63.93 (SD: ± 10.05) years,
and 67 participants (69.79%) were men. The patients were divided into two groups based
on the location of the lesion: left and right infarction groups. All baseline characteristics
of the participants (96 patients and 29 controls) are displayed in [Table 1]. Except for the homocysteine levels, no significant differences were found in terms
of baseline characteristics among the participants.
Table 1
Baseline characteristics of the study participants
|
Variables
|
Controls (N = 29)
|
Left infarction (N = 38)
|
Right infarction (N = 58)
|
p
|
|
Age (years): mean ± SD
|
65.28 ± 9.00
|
63.50 ± 9.93
|
64.21 ± 10.20
|
0.766
|
|
Sex: n (%)
|
Male
|
22 (75.9)
|
25 (65.8)
|
42 (72.4)
|
0.640
|
|
Female
|
7 (24.1)
|
13 (34.2)
|
16 (27.6)
|
|
Years of schooling
|
8.17 ± 3.40
|
7.03 ± 4.14
|
6.78 ± 4.26
|
0.307
|
|
Hypertension: n (%)
|
With
|
24 (82.8)
|
27 (71.1)
|
45 (77.6)
|
0.521
|
|
Without
|
5 (17.2)
|
11 (28.9)
|
13 (22.4)
|
|
Diabetes: n (%)
|
With
|
12 (41.4)
|
12 (31.6)
|
17 (29.3)
|
0.518
|
|
Without
|
17 (58.6)
|
26 (68.4)
|
41 (70.7)
|
|
Smoking status: n (%)
|
Never smoked
|
14 (48.3)
|
23 (60.5)
|
29(50.0)
|
0.514
|
|
Current smoker
|
15 (51.7)
|
15 (39.5)
|
29 (50.5)
|
|
Alcohol use: n (%)
|
Never
|
19 (65.5)
|
28 (73.7)
|
34 (58.6)
|
0.318
|
|
Current user
|
10 (34.5)
|
10 (26.3)
|
24 (41.4)
|
|
Carotid atherosclerosis: n (%)
|
With
|
25 (86.2)
|
37 (97.4)
|
54 (93.1)
|
0.214
|
|
Without
|
4 (13.8)
|
1 (2.6)
|
4 (6.9)
|
|
Atrial fibrillation: n (%)
|
With
|
1 (3.4)
|
2 (5.3)
|
2 (3.4)
|
0.893
|
|
Without
|
28 (96.6)
|
36 (94.7)
|
56 (96.6)
|
|
Cardiac function – ejection fraction: mean ± standard deviation
|
65.55 ± 5.30
|
66.24 ± 6.08
|
64.88 ± 5.43
|
0.511
|
|
Serum triglyceride level: mean ± SD
|
2.01 ± 2.10
|
2.16 ± 2.80
|
1.91 ± 1.83
|
0.965
|
|
Serum total cholesterol level: mean ± SD
|
4.13 ± 0.88
|
4.28 ± 1.20
|
4.50 ± 1.06
|
0.845
|
|
Serum high-density lipoprotein level: mean ± SD
|
1.13 ± 0.24
|
1.30 ± 0.74
|
1.14 ± 0.33
|
0.475
|
|
Serum low-density lipoprotein level: mean ± SD
|
2.19 ± 0.69
|
2.37 ± 0.84
|
2.49 ± 0.83
|
0.599
|
|
Homocysteine level: mean ± SD
|
8.78 ± 3.97
|
17.28 ± 14.96
|
16.68 ± 19.80
|
0.013
|
|
Uric acid level: mean ± SD
|
324.00 ± 96.00
|
320.10 ± 88.94
|
324.42 ± 94.26
|
0.981
|
Abbreviation: SD, standard deviation.
Cognitive impairment at the acute stroke phase
The patients with new-onset anterior circulation cerebral infarction had a higher
rate of CI (MoCA score < 25) than the controls (56.3% versus 27.6% respectively; p = 0.007). The proportion of patients with MCI (MoCA score: 20 to 24) in the case
group was comparable to that of the control group (20.8 versus 20.7% respectively),
as depicted in [Figure 2A]. However, the proportion of patients with severe CI (MoCA score: 0 to 19) was higher
(case group: 35.4%; controls: 6.9%). Furthermore, CI in the left infarction group
was not different from that of the right infarction group ([Figure 2B]).
Figure 2 Cognitive impairment at the acute phase of stroke. (A) The patients with new-onset anterior circulation cerebral infarction experienced
more cognitive impairment than the controls (56.3% versus 27.6% respectively; p = 0.007). (B) The cognitive impairment of the left infarction group did not differ from that of
the right infarction group (p = 0.301).
Moreover, no statistically significant differences in the score on the abstraction
domain of the MoCA were found among the participants ([Table 2]). In both the left and right infarction patients, the scores on the visuospatial/executive,
attention, and orientation domains were significantly lower than those of the controls.
Nevertheless, only those with left infarction scored significantly lower on the naming,
language, and delayed recall domains.
Table 2
Participants' scores on the Montreal Cognitive Assessment (MoCA)
|
Domains
|
Controls (N = 29)
|
Left infarction (N = 38)
|
Right infarction (N = 58)
|
p
|
|
Visuospatial/Executive: mean ± SD
|
3.93 ± 1.36
|
2.34 ± 1.98
|
2.78 ± 1.93
|
0.002
|
|
p = 0.001
|
p = 0.012
|
|
Naming: mean ± SD
|
2.86 ± 0.35
|
2.32 ± 0.99
|
2.55 ± 0.75
|
0.018
|
|
p = 0.009
|
p = 0.133
|
|
Attention: mean ± SD
|
6.34 ± 1.05
|
4.76 ± 2.07
|
5.43 ± 1.70
|
0.001
|
|
p < 0.0001
|
p = 0.036
|
|
Language: mean ± SD
|
2.97 ± 0.19
|
2.45 ± 0.83
|
2.74 ± 0.69
|
0.007
|
|
p = 0.004
|
p = 0.228
|
|
Abstraction: mean ± SD
|
1.07 ± 0.59
|
0.82 ± 0.77
|
0.90 ± 0.77
|
0.366
|
|
p = 0.263
|
p = 0.461
|
|
Delayed recall: mean ± SD
|
2.66 ± 1.45
|
1.74 ± 1.43
|
1.98 ± 1.50
|
0.037
|
|
p = 0.023
|
p = 0.080
|
|
Orientation: mean ± SD
|
5.52 ± 0.57
|
4.39 ± 1.67
|
4.71 ± 1.43
|
0.004
|
|
p = 0.002
|
p = 0.019
|
Abbreviation: SD, standard deviation.
CTP parameters
The CBF, CBV, MTT, and TTP were measured in various areas of the brain, including
the frontal, temporal, parietal, and occipital lobes, the basal ganglia, and the semioval
center ([Table 3]). Only MTT was significantly higher in the patients' frontal lobes than in those
of the controls, while the CBF, CBV, and TTP remained unchanged.
Table 3
CTP parameters among the study participants
|
Parameters:
mean ± (SD)
|
Controls (N = 29)
|
Left infarction (N = 38)
|
Right infarction (N = 58)
|
P
|
|
Frontal lobe
|
CBF, right
|
55.84(± 5.97)
|
53.66(± 7.55)
|
53.98(± 9.07)
|
0.504
|
|
CBF, left
|
57.23(± 6.23)
|
53.63(± 6.65)
|
55.18(± 7.33)
|
0.116
|
|
CBV, right
|
3.26(± 0.29)
|
3.38(± 0.49)
|
3.48(± 0.74)
|
0.243
|
|
CBV, left
|
3.28(± 0.30)
|
3.45(± 0.51)
|
3.52(± 0.90)
|
0.332
|
|
MTT, right
|
4.01(± 0.76)
|
4.50(± 0.78)
|
4.59(± 0.96)
|
0.013
|
|
p = 0.043
|
p = 0.007
|
|
MTT, left
|
3.86(± 0.63)
|
4.64(± 0.96)
|
4.46(± 0.92)
|
0.002
|
|
p = 0.001
|
p = 0.008
|
|
TTP, right
|
10.51(± 2.03)
|
10.43(± 1.01)
|
10.54(± 1.42)
|
0.945
|
|
TTP, left
|
10.67(± 1.03)
|
10.61(± 1.34)
|
10.07(± 1.38)
|
0.056
|
|
Temporal lobe
|
CBF, right
|
65.91(± 8.71)
|
65.87(± 9.91)
|
67.92(± 11.84)
|
0.572
|
|
CBF, left
|
66.75(± 11.64)
|
58.81(± 13.63)
|
67.70(± 13.42)
|
0.004
|
|
p = 0.030
|
p = 0.924
|
|
CBV, right
|
3.92(± 0.44)
|
4.11(± 0.59)
|
4.34(± 0.69)
|
0.012
|
|
p = 0.351
|
p = 0.007
|
|
CBV, left
|
3.86(± 0.54)
|
4.03(± 0.77)
|
4.23(± 1.10)
|
0.189
|
|
MTT, right
|
4.16(± 0.87)
|
4.40(± 0.69)
|
4.50(± 1.15)
|
0.304
|
|
MTT, left
|
3.97(± 1.10)
|
5.01(± 1.58)
|
4.31(± 0.94)
|
0.002
|
|
p = 0.001
|
p = 0.345
|
|
TTP, right
|
10.98(± 1.17)
|
10.35(± 0.99)
|
10.62(± 1.90)
|
0.258
|
|
TTP, left
|
10.78(± 1.09)
|
11.32(± 2.27)
|
10.18(± 1.94)
|
0.017
|
|
p = 0.400
|
p = 0.273
|
|
Parietal lobe
|
CBF, right
|
57.10(± 8.28)
|
54.22(± 8.81)
|
51.32(± 11.15)
|
0.038
|
|
p = 0.383
|
p = 0.022
|
|
CBF, left
|
58.50(± 8.57)
|
51.40(± 11.06)
|
52.63(± 10.98)
|
0.019
|
|
p = 0.014
|
p = 0.030
|
|
CBV, right
|
3.39(± 0.34)
|
3.43(± 0.55)
|
3.44(± 0.77)
|
0.929
|
|
CBV, left
|
3.47(± 0.36)
|
3.52(± 0.62)
|
5.30(± 10.46)
|
0.384
|
|
MTT, right
|
4.21(± 0.74)
|
4.54(± 0.58)
|
4.94(± 1.21)
|
0.004
|
|
p = 0.290
|
p = 0.003
|
|
MTT, left
|
4.24(± 0.75)
|
5.09(± 1.32)
|
4.68(± 1.02)
|
0.007
|
|
p = 0.003
|
p = 0.128
|
|
TTP, right
|
11.31(± 1.06)
|
10.81(± 1.00)
|
11.26(± 1.56)
|
0.183
|
|
TTP, left
|
11.22(± 1.08)
|
11.39(± 1.91)
|
10.66(± 1.44)
|
0.057
|
|
Occipital lobe
|
CBF, right
|
59.24(± 6.81)
|
59.88(± 11.95)
|
59.03(± 10.05)
|
0.920
|
|
CBF, left
|
56.05(± 8.58)
|
52.93(± 14.31)
|
57.25(± 9.52)
|
0.174
|
|
CBV, right
|
3.42(± 0.41)
|
3.75(± 0.74)
|
3.80(± 0.70)
|
0.044
|
|
p = 0.088
|
p = 0.027
|
|
CBV, left
|
3.28(± 0.46)
|
4.84(± 7.53)
|
3.67(± 0.72)
|
0.264
|
|
MTT, right
|
3.98(± 0.66)
|
4.47(± 0.77)
|
4.56(± 1.19)
|
0.032
|
|
p = 0.074
|
p = 0.019
|
|
MTT, left
|
4.07(± 0.78)
|
5.15(± 1.73)
|
4.49(± 0.89)
|
0.001
|
|
p = 0.001
|
p = 0.209
|
|
TTP, right
|
11.48(± 1.10)
|
10.89(± 1.02)
|
11.12(± 2.04)
|
0.330
|
|
TTP, left
|
11.32(± 1.02)
|
11.50(± 2.12)
|
10.71(± 1.75)
|
0.074
|
|
Semioval center
|
CBF, right
|
47.99(± 5.59)
|
46.40(± 7.12)
|
44.73(± 8.14)
|
0.146
|
|
CBF, left
|
48.68(± 5.10)
|
42.92(± 8.46)
|
44.82(± 7.88)
|
0.010
|
|
p = 0.005
|
p = 0.050
|
|
CBV, right
|
2.91(± 0.30)
|
3.00(± 0.44)
|
3.04(± 0.52)
|
0.434
|
|
CBV, left
|
2.93(± 0.29)
|
2.96(± 0.40)
|
2.99(± 0.82)
|
0.900
|
|
MTT, right
|
4.27(± 0.69)
|
4.68(± 0.68)
|
5.02(± 1.16)
|
0.003
|
|
p = 0.139
|
p = 0.001
|
|
MTT, left
|
4.24(± 0.68)
|
5.17(± 1.33)
|
4.86(± 1.16)
|
0.005
|
|
p = 0.003
|
p = 0.033
|
|
TTP, right
|
11.39(± 1.09)
|
10.82(± 1.07)
|
11.34(± 1.60)
|
0.125
|
|
TTP, left
|
11.21(± 1.06)
|
11.26(± 1.62)
|
10.77(± 1.42)
|
0.183
|
|
Basal ganglia
|
CBF, right
|
66.12(± 8.13)
|
63.25(± 8.03)
|
62.72(± 9.09)
|
0.216
|
|
CBF, left
|
67.95(± 8.67)
|
60.90(± 13.90)
|
63.97(± 11.64)
|
0.061
|
|
p = 0.033
|
p = 0.239
|
|
CBV, right
|
3.76(± 0.27)
|
3.82(± 0.46)
|
3.92(± 0.45)
|
0.222
|
|
CBV, left
|
3.82(± 0.31)
|
3.95(± 0.69)
|
3.90(± 0.41)
|
0.577
|
|
MTT, right
|
3.75(± 0.63)
|
4.04(± 0.59)
|
4.31(± 0.73)
|
0.002
|
|
p = 0.152
|
p = 0.001
|
|
MTT, left
|
3.69(± 0.52)
|
4.53(± 1.27)
|
3.97(± 0.60)
|
0.000
|
|
p = 0.000
|
p = 0.257
|
|
TTP, right
|
10.41(± 1.04)
|
9.84(± 1.26)
|
9.90(± 1.48)
|
0.180
|
|
TTP, left
|
10.11(± 1.02)
|
10.09(± 1.45)
|
9.32(± 1.33)
|
0.005
|
|
p = 0.998
|
p = 0.018
|
Abbreviations: CBF, cerebral blood flow; CBV, cerebral blood volume; CTP, computed
tomography perfusion; MTT, mean transit time; SD, standard deviation; TTP, time to
peak.
The CBF, CBV, and MTT levels in the temporal lobe of the patients differed significantly
from those of the controls. Surprisingly, significant differences in the CBF and MTT
were found only in patients with left cerebral infarction. The CBF in the left vessels
was considerably lower in these patients, while the MTT was significantly higher.
However, the CBF and MTT in right infarction patients were comparable to those of
the controls. The CBV of the right vessels increased significantly in right infarction
patients; the CBV in the left infarction patients was similar to that of the controls.
Significant differences in terms of the CBF and MTT were found in the patients' parietal
lobes compared with those of the controls. The CBF in both the left and right vessels
was significantly lower in right infarction patients compared with the controls. In
patients with left cerebral infarction, the CBF of the left vessels was significantly
lower, and the MTT was significantly higher. The MTT of the right vessels also significantly
increased in patients with right infarction.
Significant differences regarding the CBV and MTT were found in the occipital lobe
of the patients compared with those of the controls. The MTT of the left vessels significantly
increased in patients with left infarctions, and the MTT of the right vessels significantly
increased in those with right infarctions. Furthermore, compared with the controls,
the CBV of the right vessels increased significantly in right infarction patients,
but remained unchanged in left infarction patients.
Moreover, in the comparison of the semioval center of patients and controls, there
were significant differences in terms of CBF and MTT. The CBF of the left vessels
was significantly reduced in patients with left cerebral infarctions. A significant
increase was found in the MTT of the right vessels of right infarction patients. Similarly,
the MTT of the left vessels increased significantly in both right and left infarction
patients.
Finally, the CBF in the basal ganglia was significantly lower in patients with left
cerebral infarction. On the other hand, the MTT levels in the left cerebral area of
patients with left infarctions and in the right cerebral area of the patients with
right infarction were significantly increased. In addition, the TTP of the right vessels
was significantly higher in patients with right infarctions.
Associations between cognitive impairment and CTP
During the linear regression analysis, data from left infarction patients were chosen
to assess the relationship between CI and cerebrovascular reserve. This analysis revealed
that the CBF of the right vessels in the frontal lobe, the CBV of the left vessels
in the frontal lobe, CBF of the left vessels in the parietal lobe, and the MTT of
the left vessels in the occipital lobes were risk factors and formed the regression
equation (p < 0.0001; [Table 4]). The CBF of the right vessels in the frontal lobe and the MTT of the left vessels
in the occipital lobe were negatively related to the MoCA scores of patients with
left infarction. The CBV of the left vessels in the frontal lobe and the CBF of the
left vessels in the parietal lobe, on the other hand, were positively related to the
MoCA scores of patients with left infarction.
Table 4
Linear regression analysis for cognitive impairment against CTP parameters
|
Factor
|
B
|
S.E.
|
p
|
|
Left infarction
|
Constant
|
27.746
|
8.382
|
0.002
|
|
CBF, right, frontal lobe
|
-0.600
|
0.153
|
0.000
|
|
CBV, left, frontal lobe
|
5.046
|
2.121
|
0.023
|
|
CBF, left, parietal lobe
|
0.255
|
0.089
|
0.007
|
|
MTT, left, occipital lobe
|
-1.215
|
0.554
|
0.035
|
|
Right infarction
|
Constant
|
22.750
|
6.082
|
0.000
|
|
CBF, left, temporal lobe
|
-0.300
|
0.104
|
0.006
|
|
CBF, right, temporal lobe
|
0.202
|
0.091
|
0.030
|
Abbreviations: B, beta, regression coefficient; S.E., standard error; CBF, cerebral
blood flow; CBV, cerebral blood volume; CTP, computed tomography perfusion; MTT, mean
transit time; TTP, time to peak.
A linear regression analysis was also performed regarding the data from right infarction
patients to assess the relationship between CI and CTP. The CBF in the temporal lobe
was a risk factor and was included in the regression equation (p = 0.010, [Table 4]). The CBF of the right vessels in the temporal lobe was positively related to the
MoCA scores of patients with right infarction. However, the CBF of the left vessels
in the temporal lobe was negatively associated with the MoCA scores of these patients.
DISCUSSION
Cognitive function has been reported to be a predictor of the development of PSCI
in the acute stroke setting.[5]
[13] In the study by Lee et al.[14] (2020), 63.8% of the patients with acute ischemic stroke had CI (28.8% had MCI and
35.0% had severe CI). As a result, patients in the acute phase may experience a general
decline in cognitive efficiency. In the present study, we found that 56.3% (20.8%
with MCI and 35.4% with severe CI) of the patients with new-onset anterior circulation
cerebral infarction had CI at the acute phase of stroke, which is consistent with
previous studies.
The location of the lesion also affects the PSCI.[15] A study[16] with a large cohort of 410 acute ischemic stroke patients revealed that the crucial
structures for PSCI are in the left anterior circulation, such as the angular gyrus
and the basal ganglia. Furthermore, Weaver et al.[17] (2021) analyzed data from 2,950 acute ischemic stroke patients and concluded that
the appearance of infarction in the left frontal lobe, left temporal lobe, left thalamus,
and right parietal lobe was closely related to PSCI. According to Ni et al.[18] (2021), an asymmetry in hemodynamics makes the left hemisphere more vulnerable to
various risk factors than the right hemisphere. In the present study, 63.1% of the
patients with left infarction and 51.7% of those with right infarction presented with
CI. The proportion of CI was only slightly higher in the left infarction group than
in the right infarction group. This could be due to the small sample size, and, with
larger samples, this difference may become more pronounced.
The MTT may be a more accurate marker of perfusion changes relative to other time-based
perfusion parameters.[19] The present study indicated that the MTT of the patients was significantly increased
compared with that of the controls in all areas of the brain (frontal, temporal, parietal,
and occipital lobes, basal ganglia, and semioval center). Furthermore, the MTT increase
in the ipsilateral side of the lesion was greater. In the study by Chen et al.[20] (2006), MTT increases were more likely to appear in the areas with severely-reduced
perfusion reserves than in those with moderately-reduced or normal perfusion reserves.
As for the CBF parameter, it is reduced when a ischemic stroke occurs and the CBF
is inadequate.[21] The CBF was significantly lower in the temporal and parietal lobes, semioval center,
and basal ganglia of the patients of the present study, and it was also reduced significantly
on the ipsilateral side of the lesion. In addition, we found that the CBV was significantly
higher in the right occipital lobe of right cerebral infarction patients. According
to Ogasawara et al.[22] (2002), an increase in the CBV can be an early indicator of cerebral perfusion pressure.
Overall, these results demonstrated that the CTP decreased in patients with new-onset
anterior circulation cerebral infarction and was associated with the lesion. The present
study also revealed that the MoCA scores of left infarction patients were negatively
related to the CBF in the right frontal lobe and the MTT in the left occipital lobe
while positively related to the CBV in the left frontal lobe and the CBF in the left
parietal lobe.
Moreover, the MoCA scores of patients with right infarction were negatively associated
with the CBF in the left temporal lobe. Concurrently, a positive association was found
with the CBF in the right temporal lobe. These findings suggest that regional CBF
may be a more sensitive CI indicator, which is in line with previous studies. Yin
et al.[23] (2019) reported that the CBF could be used as a candidate imaging indicator to monitor
global cognitive function changes in patients with cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy.
In conclusion, CI was associated with CTP in new-onset anterior circulation cerebral
infarction patients, particularly during the acute phase of the stroke. Finally, changed
CTP could be a potential neuroimaging biomarker to predict CI during the acute phase
of stroke.
